Who Needs a BRCA Gene Test? New Beauty News Genetic testing for BRCA1 and BRCA2 can reveal if you have an increased risk of developing cancer, but it’s not universally recommended for everyone. Payal Shah, MD says testing should be considered for those with family history of certain cancers. Latest News Event in Manhattan raises over $8.5 million for research on BRCA-related cancers ABC7 News | November 2019 The Basser Center held its biannual Jean Bash fundraiser in Manhattan, bringing in more than $8.5 million to support research efforts in BRCA-related cancers. Family Matters: The Link Between Family History & BCRA Mutations ReachMD News | November 2019 Are there certain populations that are at a higher risk of BRCA mutations you should be paying close attention to? Listen to Basser Executive Director Dr. Susan Domchek's interview with ReachMD. Nina Garcia Honored At Basser Center Gala For Cancer Research Elle Magazine News | November 2019 Nina Garcia, editor-in-chief of Elle Magazine and judge on Project Runway, was honored at the Basser Jean Bash fundraiser on November 18, 2019. Nina helped to launch LATINOS & BRCA, an initiative to raise awareness of hereditary cancer in the Latino community. Why Maya Rockeymoore Cummings began her congressional campaign with a double mastectomy Washington Post News | November 2019 Basser Executive Director Susan Domchek, MD, commented on Congressional candidate Maya Rockeymore Cummings’ decision to undergo a preventive double mastectomy based on her family history of cancer. 25 Years of BRCA: How a Cancer Milestone Has Changed the Field Penn Today News | October 2019 2019 represents a specific milestone in the fight. It’s been 25 years since the BRCA1 gene was first cloned — a discovery that accelerated cancer research and opened a new path for exploration in cancer prevention and treatment. Beyoncé’s Dad Has a Mutation More African-Americans Should Be Tested For New York Times News | October 2019 Basser Young Leadership Council co-chair Erika Stallings writes for The New York Times about the importance of genetic testing for African Americans. Breast Cancer is a Family Legacy for This Young Latina Philadelphia Inquirer News | October 2019 For Hispanic Heritage Month and Breast Cancer Awareness Month, Alejandra Campoverdi writes for the Philadelphia Inquirer about her personal experience with hereditary cancer. Breast Cancer, Genetics and the Milestone that Keeps Bringing Hope Closer Philadelphia Inquirer News | October 2019 Basser Executive Director Susan Domchek, MD, marks 25 years since BRCA1 was first cloned. She explores the advances in the field since that milestone and looks to the future for areas of growth. Dr. Domchek on Results of the MEDIOLA Trial in BRCA-Mutated Metastatic Breast Cancer OncLive News | October 2019 Basser Executive Director, Susan Domchek, MD, discusses the results of the MEDIOLA trial in germline BRCA-mutated metastatic breast cancer. Expert Discusses the Selection of Individuals for Germline Testing Based on Breast Cancer Risk Targeted Oncology News | October 2019 Susan Domchek, MD, Executive Director of the Basser Center, discusses current guidelines and evolving best practices about when to order genetic testing for patients. Home Genetic Testing Kits Sound like a Great Idea — Until They Aren’t Philadelphia Inquirer News | October 2019 Throughout October, Penn Medicine physicians, patients, and advocates are contributing to breast cancer awareness month with a series of op-eds for the Philadelphia Inquirer. In this week’s piece, Dana Farengo Clark, MS, LCGC, a senior genetics counselor at the Basser Center, talked about the risks and drawbacks of at-home genetic testing. Mathew Knowles Reveals He is Battling Breast Cancer Good Morning America News | October 2019 Matthew Knowles shares his story with Good Morning America and discusses male breast cancer and BRCA. Basser Executive Director Susan Domchek, MD, was interviewed for the piece and shares that "men with BRCA2 mutations have a particular increased risk of male breast cancer" and other cancers. Meet the 2019 Breast Health Champions Philadelphia Magazine News | October 2019 Basser Executive Director Susan Domchek, MD, has been featured as one of Philadelphia Magazine's 2019 Breast Health Champions. In this interview with her, she discusses the role of medical oncologists, hereditary cancer, and what both men and women should know about their potential risk for breast cancer. Wellness Wednesday: Breast Cancer in Men WOSU Radio News | October 2019 WOSU Radio’s “All Sides with Ann Fisher” interviewed Payal D. Shah, MD, an assistant professor of Hematology-Oncology and a member of the Basser Center, about breast cancer in men, genetic risks, and what patients should know. What’s Your Family History? with Susan M. Domchek, MD Real Pink News | October 2019 Basser Executive Director Susan Domchek, MD, discusses the importance of knowing your family health history on Real Pink, the Susan G. Komen podcast. Dr. Domchek on Potential Benefits of Biosimilars in Oncology OncLive News | September 2019 Susan Domchek, MD, Executive Director of the Basser Center, discusses the potential benefits of biosimilars in oncology. Biosimilars are like "generic" medications; they are officially approved versions of innovative, original products. Penn’s Basser Center for BRCA Chooses Two Cambridge Researchers for 2019 Basser Global Prize Penn Medicine News News | September 2019 Douglas Easton, PhD, and Antonis Antoniou, PhD, have been named recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre. Broadening Criteria for BRCA1/2 Evaluation Placing the USPSTF Recommendation in Context Journal of the American Medical Association News | August 2019 For the Journal of the American Medical Association, Basser executive director Susan Domchek, MD, and Memorial Sloan Kettering's Mark Robson, MD, discuss limitations around the new United States Preventive Services Task Force guidelines for BRCA genetic testing. Pagination First page« First Previous page‹‹ … Page7 Page8 Page9 Page10 Current page11 Page12 Page13 Page14 Page15 Next page›› Last pageLast »
Who Needs a BRCA Gene Test? New Beauty News Genetic testing for BRCA1 and BRCA2 can reveal if you have an increased risk of developing cancer, but it’s not universally recommended for everyone. Payal Shah, MD says testing should be considered for those with family history of certain cancers.
Event in Manhattan raises over $8.5 million for research on BRCA-related cancers ABC7 News | November 2019 The Basser Center held its biannual Jean Bash fundraiser in Manhattan, bringing in more than $8.5 million to support research efforts in BRCA-related cancers.
Family Matters: The Link Between Family History & BCRA Mutations ReachMD News | November 2019 Are there certain populations that are at a higher risk of BRCA mutations you should be paying close attention to? Listen to Basser Executive Director Dr. Susan Domchek's interview with ReachMD.
Nina Garcia Honored At Basser Center Gala For Cancer Research Elle Magazine News | November 2019 Nina Garcia, editor-in-chief of Elle Magazine and judge on Project Runway, was honored at the Basser Jean Bash fundraiser on November 18, 2019. Nina helped to launch LATINOS & BRCA, an initiative to raise awareness of hereditary cancer in the Latino community.
Why Maya Rockeymoore Cummings began her congressional campaign with a double mastectomy Washington Post News | November 2019 Basser Executive Director Susan Domchek, MD, commented on Congressional candidate Maya Rockeymore Cummings’ decision to undergo a preventive double mastectomy based on her family history of cancer.
25 Years of BRCA: How a Cancer Milestone Has Changed the Field Penn Today News | October 2019 2019 represents a specific milestone in the fight. It’s been 25 years since the BRCA1 gene was first cloned — a discovery that accelerated cancer research and opened a new path for exploration in cancer prevention and treatment.
Beyoncé’s Dad Has a Mutation More African-Americans Should Be Tested For New York Times News | October 2019 Basser Young Leadership Council co-chair Erika Stallings writes for The New York Times about the importance of genetic testing for African Americans.
Breast Cancer is a Family Legacy for This Young Latina Philadelphia Inquirer News | October 2019 For Hispanic Heritage Month and Breast Cancer Awareness Month, Alejandra Campoverdi writes for the Philadelphia Inquirer about her personal experience with hereditary cancer.
Breast Cancer, Genetics and the Milestone that Keeps Bringing Hope Closer Philadelphia Inquirer News | October 2019 Basser Executive Director Susan Domchek, MD, marks 25 years since BRCA1 was first cloned. She explores the advances in the field since that milestone and looks to the future for areas of growth.
Dr. Domchek on Results of the MEDIOLA Trial in BRCA-Mutated Metastatic Breast Cancer OncLive News | October 2019 Basser Executive Director, Susan Domchek, MD, discusses the results of the MEDIOLA trial in germline BRCA-mutated metastatic breast cancer.
Expert Discusses the Selection of Individuals for Germline Testing Based on Breast Cancer Risk Targeted Oncology News | October 2019 Susan Domchek, MD, Executive Director of the Basser Center, discusses current guidelines and evolving best practices about when to order genetic testing for patients.
Home Genetic Testing Kits Sound like a Great Idea — Until They Aren’t Philadelphia Inquirer News | October 2019 Throughout October, Penn Medicine physicians, patients, and advocates are contributing to breast cancer awareness month with a series of op-eds for the Philadelphia Inquirer. In this week’s piece, Dana Farengo Clark, MS, LCGC, a senior genetics counselor at the Basser Center, talked about the risks and drawbacks of at-home genetic testing.
Mathew Knowles Reveals He is Battling Breast Cancer Good Morning America News | October 2019 Matthew Knowles shares his story with Good Morning America and discusses male breast cancer and BRCA. Basser Executive Director Susan Domchek, MD, was interviewed for the piece and shares that "men with BRCA2 mutations have a particular increased risk of male breast cancer" and other cancers.
Meet the 2019 Breast Health Champions Philadelphia Magazine News | October 2019 Basser Executive Director Susan Domchek, MD, has been featured as one of Philadelphia Magazine's 2019 Breast Health Champions. In this interview with her, she discusses the role of medical oncologists, hereditary cancer, and what both men and women should know about their potential risk for breast cancer.
Wellness Wednesday: Breast Cancer in Men WOSU Radio News | October 2019 WOSU Radio’s “All Sides with Ann Fisher” interviewed Payal D. Shah, MD, an assistant professor of Hematology-Oncology and a member of the Basser Center, about breast cancer in men, genetic risks, and what patients should know.
What’s Your Family History? with Susan M. Domchek, MD Real Pink News | October 2019 Basser Executive Director Susan Domchek, MD, discusses the importance of knowing your family health history on Real Pink, the Susan G. Komen podcast.
Dr. Domchek on Potential Benefits of Biosimilars in Oncology OncLive News | September 2019 Susan Domchek, MD, Executive Director of the Basser Center, discusses the potential benefits of biosimilars in oncology. Biosimilars are like "generic" medications; they are officially approved versions of innovative, original products.
Penn’s Basser Center for BRCA Chooses Two Cambridge Researchers for 2019 Basser Global Prize Penn Medicine News News | September 2019 Douglas Easton, PhD, and Antonis Antoniou, PhD, have been named recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre.
Broadening Criteria for BRCA1/2 Evaluation Placing the USPSTF Recommendation in Context Journal of the American Medical Association News | August 2019 For the Journal of the American Medical Association, Basser executive director Susan Domchek, MD, and Memorial Sloan Kettering's Mark Robson, MD, discuss limitations around the new United States Preventive Services Task Force guidelines for BRCA genetic testing.
